Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD.

Candesartan treatment tended to improve the prognostic benefits after femoral artery stent implantation, suggesting that an antiproliferative effect after stenting may need higher doses than an ...

Stent implantation followed by kissing balloon ... A more extreme example is shown in Figure 5, where the right superficial femoral artery is occluded with thrombus extending distally into the ...

PTAB with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to bypass lesions in the superficial femoral artery, by using stents routed through the femoral ...

A discussion of a challenging case of renal artery denervation for resistant hypertension. Hypertension (HTN) is estimated to ...